NCT00202124View on ClinicalTrials.gov

Double Blind Study of Trp01 in Patients With Alzheimer's Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 30, 2001

Study Completion Date

March 31, 2002

Conditions
Alzheimer's Disease
Interventions
DRUG

Tryptophan

Trial Locations (1)

K7L 3N6

Queen's University, Kingston

All Listed Sponsors
lead

Queen's University

OTHER

NCT00202124 - Double Blind Study of Trp01 in Patients With Alzheimer's Disease | Biotech Hunter | Biotech Hunter